X4 Pharmaceuticals, Inc.
Methods for treating immunodeficiency disease

Last updated:

Abstract:

The present invention relates to methods of treating patients with WHIM syndrome or related disorders, such as myelokathexis, in which X4P-001 is administered in order to reduce the activity of CXCR4. The methods demonstrate surprising effectiveness, with comparatively little toxicity.

Status:
Grant
Type:

Utility

Filling date:

28 Feb 2020

Issue date:

11 Jan 2022